<?xml version="1.0" encoding="UTF-8"?>
<ref id="B124-pharmaceutics-13-00387">
 <label>124.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lopalco</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Curci</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lopedota</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cutrignelli</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Laquintana</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Franco</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Denora</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate</article-title>
  <source>Eur. J. Pharm. Sci.</source>
  <year>2019</year>
  <volume>127</volume>
  <fpage>339</fpage>
  <lpage>350</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejps.2018.11.013</pub-id>
  <pub-id pub-id-type="pmid">30447284</pub-id>
 </element-citation>
</ref>
